My Path Forward With Type 2 Diabetes

If you have type 2 diabetes, you likely feel its impact daily. Whether it’s taking extra care with your diet to keep your blood sugar in check or simply managing stress, the disease can take a physical and mental toll. 

Knowing you are not alone in this journey and hearing from someone who has had a similar experience may inspire a new path forward. Here, one woman shares her story and treatment journey.

Medically Reviewed By Kelly Wood, MD

Sponsored and Developed by Lilly USA, LLC.

Liz Davis

What is Mounjaro® (tirzepatide)?

Mounjaro® (mown-JAHR-OH) is an injectable medicine for adults with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose).

It is not known if Mounjaro can be used in people who have had inflammation of the pancreas (pancreatitis). Mounjaro is not for use in people with type 1 diabetes. It is not known if Mounjaro is safe and effective for use in children under 18 years of age.

Select Safety Information

Warning: Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Mounjaro and medicines that work like Mounjaro caused thyroid tumors, including thyroid cancer. It is not known if Mounjaro will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Do not take Mounjaro if you or any of your family have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

When Liz Davis was diagnosed with prediabetes in her late 20s, she didn’t think too much of it. 

She had already known that she was at higher risk for type 2 diabetes due to her family history of insulin resistance and her polycystic ovarian syndrome (PCOS)—a condition that can cause irregular periods due to an imbalance of reproductive hormones1—but she was young, busy, and otherwise healthy. 

A few years later, Liz began to experience symptoms such as trouble sleeping and a constant thirst. Like many young people in her situation, she’d been so absorbed with graduate school and her work that she hadn’t seen a physician in years.

“I tried to stay healthy through lifestyle, but it was tough. I was always very stressed, and I didn’t have time to take care of myself,” she recalls. In 2018, at the age of 33, Liz finally saw a physician who ran her bloodwork. That’s when she heard that she’d progressed from pre-diabetes to type 2 diabetes.

Finding the Right Treatment Fit

“When I was first diagnosed with type 2 diabetes, it was devastating. All I could think of was that it would make my life really difficult. But now I can plan my life around myself, rather than my diagnosis.”

After her diagnosis, Liz tried two different medications and made a few lifestyle changes to control her diabetes, but she still struggled to regulate her glucose levels. In the spring of 2022, her father, a retired physician, told her about recent clinical trials on a type 2 diabetes drug called Mounjaro® (tirzepatide), an injectable, prescription medicine available in a 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg per 0.5 mL single dose pen. 

“My dad knew I had been struggling, and that I wanted to try a different treatment,” Liz recalls. “I read the studies my dad gave me and took them to my doctor, who also felt Mounjaro could be a great option for me.” Liz began taking Mounjaro in July 2022, two months after it was approved by the U.S. Food and Drug Administration.

Initially, Liz was intimidated by Mounjaro as she’d never been on an injectable medication before. “It was hard for me to wrap my mind around taking a medicine that required an injection, as I’ve been afraid of needles my whole life!” she recalls. “In some ways, I also felt like a failure, since I hadn’t been able to get my glucose under control through diet and exercise.”

Thankfully, Liz’s doctor walked her through her first injection. “I was pleasantly surprised at how easy it was to use the Mounjaro single dose pen,” she says. “I had been used to all the times I pricked my finger to check my blood sugar, so I didn’t know what to expect, but with Mounjaro it comes in an easy-to-use pen.”*

*Before using the Mounjaro Pen, read the Instructions for Use (IFU) or watch how to use the Mounjaro Pen at www.mounjaro.com. In a study of adults with type 2 diabetes for another medicine that uses the same single-dose pen as Mounjaro, 99% said that, after adequate training, the single-dose pen was easy to use. The IFU for the Mounjaro single-dose pen differ from the IFU provided in the study.

Soon after she started Mounjaro, along with diet and exercise, Liz began to see a drop in her A1C. “Within a few weeks, I noticed positive changes in my blood sugar and realized that I was making real progress in managing my type 2 diabetes,” she says. 

Liz Davis

A New Lifestyle, A New Life

Today, Liz’s diabetes is very well controlled. After starting Mounjaro and continuing to watch her diet and exercising more frequently,  her A1C—a blood test that measures average blood sugar levels over the last three months—was below 7%.

In studies, up to 90% of people taking Mounjaro, along with diet and exercise, reached an A1C of under 7%.

In studies with or without other diabetes medications, the percentage of people taking Mounjaro who reached an A1C of less than 7% ranged from 75% (5 mg) to 90% (10 mg). People had an average starting A1C of 7.9% to 8.6% across the 5-mg, 10-mg, and 15-mg doses. A 40-week study was conducted to see if Mounjaro 5-mg, 10-mg, and 15-mg plus a basal insulin worked better than basal insulin alone. 90% of people taking Mounjaro 10-mg plus basal insulin achieved an A1C of under 7%.

“Having my A1C levels come down is so amazing—I have more time and ‘brain space’ to think about and do the things I enjoy, since I can be less focused on monitoring my glucose all day,” she says.

While Mounjaro is not a weight loss drug, Liz has also noticed it has helped decrease how much food she eats. “I eat less and I’m able to focus on maintaining a balanced diet.”

Plus, part of Liz’s commitment to a healthy lifestyle is keeping up with her favorite activity—walking. “I take my dogs to the beach for long romps and it feels great,” she exclaims. “Now, I focus on small, but sustainable changes, like going for a walk or cooking at home instead of ordering in.”

Being an Active Participant in Your Own Care

The best advice Liz has for anyone newly diagnosed with type 2 diabetes?

“Always be an advocate for yourself,” she says. “Never be afraid to bring up concerns to your doctor, get your annual physical, and never, ever take your health for granted.”

She also recommends connecting with others who have type 2 diabetes via online resources, including social media. “It’s important to find a community,” she stresses. “Remember, there are a lot of people out there with type 2 diabetes, and we are better when we can go through it together. A good relationship with your doctor is important, but it’s also crucial to see how other people live their lives with this condition. Learning from them can be motivating and empowering—and will help you feel less alone.”

Since getting accurate health information is essential, Liz recommends that adults diagnosed with type 2 diabetes talk to their healthcare provider about their treatment options and visit the Mounjaro website to learn more about this weekly injection, as well as lifestyle tips for living with type 2 diabetes. 

“With the help of Mounjaro, I know achieving my A1C goal is possible,” she says. “I hope my story can show others that they too can find a new path forward with their type 2 diabetes.”

SAFETY SUMMARY WITH WARNINGS AND INDICATION

Warnings – Mounjaro® (tirzepatide) may cause tumors in the thyroid, including thyroid cancer. Watch for possible symptoms, such as a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath. If you have any of these symptoms, tell your healthcare provider.

  • Do not use Mounjaro if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).
  • Do not use Mounjaro if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • Do not use Mounjaro if you are allergic to it or any of the ingredients in Mounjaro.

Mounjaro may cause serious side effects, including:

Inflammation of the pancreas (pancreatitis). Stop using Mounjaro and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.

Low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Mounjaro with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, or mood changes, hunger, weakness and feeling jittery.

Serious allergic reactions. Stop using Mounjaro and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, problems breathing or swallowing, severe rash or itching, fainting or feeling dizzy, and very rapid heartbeat.

Kidney problems (kidney failure). In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems to get worse. It is important for you to drink fluids to help reduce your chance of dehydration.

Severe stomach problems. Stomach problems, sometimes severe, have been reported in people who use Mounjaro. Tell your healthcare provider if you have stomach problems that are severe or will not go away.

Changes in vision. Tell your healthcare provider if you have changes in vision during treatment with Mounjaro.

Gallbladder problems. Gallbladder problems have happened in some people who use Mounjaro. Tell your healthcare provider right away if you get symptoms of gallbladder problems, which may include pain in your upper stomach (abdomen), fever, yellowing of skin or eyes (jaundice), and clay-colored stools.

Common side effects

The most common side effects of Mounjaro include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach (abdominal) pain. These are not all the possible side effects of Mounjaro. Talk to your healthcare provider about any side effect that bothers you or doesn’t go away.

Tell your healthcare provider if you have any side effects. You can report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch .

Before using Mounjaro

  • Your healthcare provider should show you how to use Mounjaro before you use it for the first time.
  • Talk to your healthcare provider about low blood sugar and how to manage it.
  • If you take birth control pills by mouth, talk to your healthcare provider before you use Mounjaro. Birth control pills may not work as well while using Mounjaro. Your healthcare provider may recommend another type of birth control for 4 weeks after you start Mounjaro and for 4 weeks after each increase in your dose of Mounjaro.

Review these questions with your healthcare provider:

  • Do you have other medical conditions, including problems with your pancreas or kidneys, or severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems digesting food?
  • Do you take other diabetes medicines, such as insulin or sulfonylureas?
  • Do you have a history of diabetic retinopathy?
  • Are you pregnant, plan to become pregnant, breastfeeding, or plan to breastfeed? It is not known if Mounjaro will harm your unborn baby or pass into your breast milk.
  • Do you take any other prescription medicines or over-the-counter drugs, vitamins, or herbal supplements?

How to take

  • Read the Instructions for Use that come with Mounjaro.
  • Use Mounjaro exactly as your healthcare provider says.
  • Mounjaro is injected under the skin (subcutaneously) of your stomach (abdomen), thigh, or upper arm.
  • Use Mounjaro 1 time each week, at any time of the day.
  • Do not mix insulin and Mounjaro together in the same injection.
  • You may give an injection of Mounjaro and insulin in the same body area (such as your stomach area), but not right next to each other.
  • Change (rotate) your injection site with each weekly injection. Do not use the same site for each injection.
  • If you take too much Mounjaro, call your healthcare provider or seek medical advice promptly.

INDICATION 

Mounjaro® (mown-JAHR-OH) is an injectable medicine for adults with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose).

  • It is not known if Mounjaro can be used in people who have had inflammation of the pancreas (pancreatitis). Mounjaro is not for use in people with type 1 diabetes. It is not known if Mounjaro is safe and effective for use in children under 18 years of age.

Learn more

Mounjaro is a prescription medicine. For more information, call 1-833-807-MJRO (833-807-6576) or go to www.mounjaro.com.

This summary provides basic information about Mounjaro but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your healthcare provider. Be sure to talk to your healthcare provider about Mounjaro and how to take it. Your healthcare provider is the best person to help you decide if Mounjaro is right for you.

TR CON CBS 14SEP2022

Mounjaro® and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

PP-TR-US-1489 12/2023 © Lilly USA, LLC 2023. All rights reserved. 

Learn More About Mounjaro here

Sources:

  1. Office of Women’s Health. Polycystic Ovary Syndrome.